Press Releases

The Alliance for Regenerative Medicine Releases Report Analyzing Workforce Needed to Support Sustainable Biomanufacturing Of Cell And Gene Therapies In The United States

March 16, 2023

Washington, DC

ARM Releases Statement Responding to Health & Human Services Secretary Becerra’s “Report In Response to the Executive Order on Lowering Prescription Drug Costs for Americans” and Selected Models

February 15, 2023

Washington, DC

ARM applauds the HHS announcement that the Center for Medicare and Medicaid Innovation (CMMI) will test a “Cell and Gene Therapy Access Model” to administer multi-state outcomes-based agreements in Medicaid programs for transformative cell and gene therapies.

The Alliance for Regenerative Medicine Appoints Mark Battaglini as Chief Strategy Officer

January 3, 2023

Washington, D.C.

The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the cell and gene therapy sector, announced the appointment of Mark Battaglini to the newly created position of Chief Strategy Officer, effective today.

Patients will benefit if Europe modernizes its policy framework to reflect the distinct promise of cell and gene therapy, the Alliance for Regenerative Medicine will highlight in 29 November EU Parliament event

November 24, 2022

Brussels

The European Union can reverse its declining competitiveness and ensure patient access to transformative treatments if it modernizes its policy and regulatory framework to reflect the distinct promise of cell and gene therapies as the future of medicine, the Alliance for Regenerative Medicine (ARM) will say during an event at the EU Parliament on 29 November.